Previous 10 | Next 10 |
In January 2020, only 0.24% of total medical claims in the U.S. were telemedicine-related. One year later, they totaled 7%. It took 15 years for e-commerce penetration to rise from less than 1% to over 7%. The pandemic helped telemedicine do it in one. Population-wide immunity to ...
Current economic data is certainly strong - although not universally so - but the bond and currency markets may be pointing to some weakness ahead. The copper to gold ratio which peaked in early March, leading bond yields by a full month, has recently resumed its uptrend. The comm...
Since U.S. Treasury bonds have fallen more than -20% in value, it looks like we might've seen a short-term bottom and an opportunity to profit in the bond market. Which sectors are performing well in the intermediate term, as well as those that are taking a breather in the short term....
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of thi...
In our opinion, telehealth will remain the leading segment of the internet healthcare market as the market shifts away from in-person medical visits. According to Apple CEO Tim Cook, “I believe, if you zoom out into the future, and you look back, and you ask the question, ...
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets. LeMaitre Vascular Inc. manufactures and distributes medical devices for the tre...
Risk assets continued their historic run last week with EM equities and commodities leading the way. Bonds sold off as the 10-year Treasury note yield broke above 1.20% for the first time since the lows last spring. The 10-year TIPS yield closed the week at 1.02%, near the all-tim...
After a dramatic year of volatility, the U.S. stock market ended 2020 at record highs. Can this momentum continue this year? ESG investments clearly outperformed in 2020. 2021 should be a year of much better cash flow for companies. For further details see: A Stock Picke...
The pandemic has sped up structural trends that are benefiting sectors such as technology and healthcare - and we believe these trends are not fully priced in. Rising inflation expectations have driven up U.S. 10-year Treasury yields but to a lesser degree than in the past, in line wi...
2020 was a busy year for global healthcare with unprecedented efforts to develop vaccines, treatments, and diagnostics for COVID-19. Deal flow in the sector continued to gain momentum in 2020, with M&A transactions and product licensing deals totalling five-year highs as large-cap...
News, Short Squeeze, Breakout and More Instantly...
John Hancock Multifactor Healthcare Company Name:
JHMH Stock Symbol:
NYSE Market:
John Hancock Investment Management announces changes to its ETF lineup Canada NewsWire $ unless otherwise stated ...
John Hancock Investment Management celebrates five-year anniversary of its original ETF suite PR Newswire BOSTON, Sept. 28, 2020 TSX/NYSE/PSE: MFC SEHK: 945 BOSTON , Sept. 28, 2020 /PRNewswire/ - John Hancock Investment Managem...
BOSTON , Feb. 5, 2019 /PRNewswire/ -- John Hancock Investments today announced that the expense ratios for its nine sector ETFs subadvised by Dimensional Fund Advisors, LP, its Floating Rate Income Fund subadvised by Bain Capital Credit, and its Small Cap Value Fund subadvised by Wel...